Middle East, North Africa, Afghanistan & Pakistan vs Vietnam: Immunization, HepB3
Immunization, HepB3 over time
- Middle East, North Africa, Afghanistan & Pakistan
- Vietnam
How they compare
Vietnam currently reports 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 12.6%.
That makes Vietnam's figure about 1.1 times Middle East, North Africa, Afghanistan & Pakistan's.
The two have swapped places 8 times across 22 shared years of data; in 2003 it was Vietnam ahead.
Middle East, North Africa, Afghanistan & Pakistan ranks 24th and Vietnam ranks 26th of 47 groups.
Vietnam has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan | Vietnam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 72.6% | 86.7% | 14.1% | Vietnam |
| 2010s | 80.5% | 88.5% | 8.0% | Vietnam |
| 2020s | 83.4% | 86.0% | 2.6% | Vietnam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Middle East, North Africa, Afghanistan & Pakistan or Vietnam?
- Vietnam, at 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan as of 2024.
- What is the difference in immunization, hepb3 between Middle East, North Africa, Afghanistan & Pakistan and Vietnam?
- 12.6%, with Vietnam ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan and Vietnam?
- 22 years are reported by both, from 2003 to 2024.
- How do Middle East, North Africa, Afghanistan & Pakistan and Vietnam rank globally for immunization, hepb3?
- Middle East, North Africa, Afghanistan & Pakistan ranks 24th and Vietnam ranks 26th of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.